IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML | ClinicalTrials HQ

Ask about research services

Swipe the table sideways for more columns.

Trial	Conditions	Status	Phase	Updated	More info	NCT ID
IMPACT-AML: Randomized Pragmatic Clinical Trial for Relapsed or Refractory AML	Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, acute myeloid leukemia, hematologic disorder, leukemia, myeloid leukemia, neoplasm	Recruiting	Phase 3	2024-05-17		NCT06418776

3 results · Page 1 of 1

Swipe the table sideways for more columns.

Organizations	Linked trials
Federal State Budgetary Institution, V. A. Almazov Federal North-West Medical Research Centre, of the Ministry of Health	10
National Research Center for Hematology, Russia	5
St. Petersburg State Pavlov Medical University	16

1 results · Page 1 of 1

Swipe the table sideways for more columns.

Research sites	City	Country	Linked trials
National Research Center for Hematology	Moscow	Russia	2